THE USE OF FRENQUEL IN THE TREATMENT OF DISTURBED PATIENTS WITH PSYCHOSES OF LONG DURATION
Abstract
In this double-blind study of the effect of Frenquel on 39 chronically hospitalized disturbed psychotic patients, the investigators were entirely unaware of whether the patients were receiving Frenquel or the placebo until after they had committed themselves on the patient's status. Despite the long-standing nature of the disturbances in behavior significant improvement was observed in a large proportion of the patients with various types of schizophrenic reactions. We feel these results are most encouraging for further use of this drug in patients with psychoses.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
